ZA956993B - Methods of inhibiting demyelinating and desmyelinating diseases. - Google Patents

Methods of inhibiting demyelinating and desmyelinating diseases.

Info

Publication number
ZA956993B
ZA956993B ZA9506993A ZA956993A ZA956993B ZA 956993 B ZA956993 B ZA 956993B ZA 9506993 A ZA9506993 A ZA 9506993A ZA 956993 A ZA956993 A ZA 956993A ZA 956993 B ZA956993 B ZA 956993B
Authority
ZA
South Africa
Prior art keywords
desmyelinating
demyelinating
inhibiting
diseases
methods
Prior art date
Application number
ZA9506993A
Other languages
English (en)
Inventor
Andrew Lawrence Glasebrook
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA956993B publication Critical patent/ZA956993B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9506993A 1994-08-22 1995-08-21 Methods of inhibiting demyelinating and desmyelinating diseases. ZA956993B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/294,238 US5434166A (en) 1994-08-22 1994-08-22 Methods of inhibiting demyelinating and desmyelinating diseases

Publications (1)

Publication Number Publication Date
ZA956993B true ZA956993B (en) 1997-02-21

Family

ID=23132498

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9506993A ZA956993B (en) 1994-08-22 1995-08-21 Methods of inhibiting demyelinating and desmyelinating diseases.

Country Status (10)

Country Link
US (2) US5434166A (es)
EP (1) EP0769943A4 (es)
JP (1) JPH10505823A (es)
AU (1) AU3368595A (es)
BR (1) BR9508732A (es)
CA (1) CA2198114A1 (es)
IL (1) IL115015A0 (es)
MX (1) MX9701360A (es)
WO (1) WO1996005823A1 (es)
ZA (1) ZA956993B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6251920B1 (en) 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6395494B1 (en) * 1993-05-13 2002-05-28 Neorx Corporation Method to determine TGF-β
US5770609A (en) 1993-01-28 1998-06-23 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US5595722A (en) * 1993-01-28 1997-01-21 Neorx Corporation Method for identifying an agent which increases TGF-beta levels
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
WO1996040098A2 (en) 1995-06-07 1996-12-19 Neorx Corporation Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
US6417198B1 (en) 1993-12-21 2002-07-09 Eli Lilly And Company Methods of inhibiting CNS problems in post-menopausal women
IL120266A (en) 1996-02-28 2005-05-17 Pfizer Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions
TW442286B (en) * 1996-02-28 2001-06-23 Pfizer New therapeutic uses of estrogen agonists
ZA982877B (en) * 1997-04-09 1999-10-04 Lilly Co Eli Treatment of central nervous system disorders with selective estrogen receptor modulators.
WO1998046588A2 (en) * 1997-04-11 1998-10-22 Neorx Corporation Compounds and therapies for the prevention of vascular and non-vascular pathologies
US5990129A (en) * 1997-09-23 1999-11-23 Eli Lilly And Company Methods for regulating trkA expression
WO2000018394A1 (en) * 1998-09-28 2000-04-06 The Johns Hopkins University Adrenoleukodystrophy treatments and drug screening
CZ20013912A3 (cs) 1999-05-04 2002-05-15 Strakan Limited Androgen glykosid, sloučenina, testosteron-ß-D-glukosid, 5 alfa-Dihydrotestosteron- 17ß-D-glukosid, farmaceutický prostředek a pouľití sloučeniny
US6458838B1 (en) 1999-09-28 2002-10-01 Johns Hopkins University Adrenoleukodystrophy treatments
US6329564B1 (en) * 1999-11-29 2001-12-11 Michael Lebner Bandage for wound or incision closure
KR20050091058A (ko) * 2003-01-06 2005-09-14 와이어쓰 다발성 경화증을 치료하기 위한 에스트로겐 수용체 알파조절제의 용도
ES2546526T3 (es) 2009-07-24 2015-09-24 Baylor College Of Medicine Métodos de modulación de ácidos de cadena ramificada y usos de los mismos
AU2017308131A1 (en) * 2016-08-12 2019-03-07 The Regents Of The University Of California Remyelination therapies
JP2020526502A (ja) 2017-06-28 2020-08-31 ベイラー カレッジ オブ メディスンＢａｙｌｏｒ Ｃｏｌｌｅｇｅ Ｏｆ Ｍｅｄｉｃｉｎｅ 尿素サイクル異常症を処置するための併用療法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US5075321A (en) * 1987-03-24 1991-12-24 University Of Pennsylvania Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
US5521198A (en) * 1993-12-21 1996-05-28 Eli Lilly And Company Methods of inhibiting autoimmune diseases
US5708009A (en) * 1993-12-21 1998-01-13 Eli Lilly And Company Methods of inhibiting myeloperoxidase activity
US5552415A (en) * 1993-12-21 1996-09-03 Eli Lilly And Company Method of inhibiting Alzheimer's Disease

Also Published As

Publication number Publication date
MX9701360A (es) 1997-05-31
WO1996005823A1 (en) 1996-02-29
IL115015A0 (en) 1995-12-08
BR9508732A (pt) 1997-11-11
EP0769943A1 (en) 1997-05-02
JPH10505823A (ja) 1998-06-09
EP0769943A4 (en) 1999-07-07
CA2198114A1 (en) 1996-02-29
AU3368595A (en) 1996-03-14
US5434166A (en) 1995-07-18
US5530010A (en) 1996-06-25

Similar Documents

Publication Publication Date Title
ZA956993B (en) Methods of inhibiting demyelinating and desmyelinating diseases.
GB2298440B (en) Well treatment
AU7905894A (en) Treatment of poultry
ZA965088B (en) Methods of preventing or treating allergles
EP0851759A4 (en) COMPOUNDS AND RELATED METHODS
GB9526560D0 (en) Use of 2-Amino-Heterocycles
HU9403657D0 (en) Methods of inhibiting pulmonary hypertenzive diseases
PH31599A (en) Methods of inhibiting autoimmune diseases.
GB9519033D0 (en) Treatment
EP0761718A3 (de) Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
IL118631A0 (en) Pyridazinone and processes for their preparation
IL109656A0 (en) Process for the manufacture of androstane-17-carbothioates and androstane-17-carbothioates prepared thereby
SG42329A1 (en) Use of phenylcyclohexylcarboxamides
EP0761721A3 (de) Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
EP0720589A4 (en) SYSTEM FOR TREATING ALDEHYDES
EP0761719A3 (de) Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
EP0736296A3 (de) Sarg
EP0761720A3 (de) Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
GB9525234D0 (en) Process compound and use
GB9504876D0 (en) Compounds and process
AU2316795A (en) Treatment of metal granules
EP0792122A4 (en) CATHETER
GB9709084D0 (en) Methods of inhibiting immune-complex diseases
AU3163795A (en) Treatment of autoimmune diseases
SG64924A1 (en) Inhibiting photodecompostion of 3-substituted-2- oxindoles